JPRN-jRCT2080222837已完成2 期
A multi-center, international, double-blind, randomized, placebo-controlled, dose-finding, parallel-group study to assess the efficacy and safety of clazosentan in reducing cerebral vasospasm in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping
Actelion Pharmaceuticals Japan Ltd.0 个研究点目标入组 168 人开始时间: 2015年4月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 168
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •patients treated by surgical clipping
- •WFNS GradeI - IV
- •Fisher group 3
排除标准
- •Presence of cerebral vasospasm seen prior to the clipping procedure etc.
研究者
相似试验
已完成
4 期
Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR (Quetiapine Fumarate) in Adult Patients with Acute ManiaCTRI/2009/091/000538AstraZeneca350
进行中（未招募）
1 期
An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute ManiaAcut mania in subjects with bipolar I disorderMedDRA version: 9.1Level: PTClassification code 10004939Term: Bipolar I disorderEUCTR2008-007190-20-BEAstraZeneca AB350
进行中（未招募）
不适用
An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute ManiaAcut mania in subjects with bipolar I disorderMedDRA version: 9.1Level: PTClassification code 10004939Term: Bipolar I disorderEUCTR2008-007190-20-DEAstraZeneca AB350
进行中（未招募）
不适用
An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in Adult Patients with Acute ManiaAcut mania in subjects with bipolar I disorderMedDRA version: 9.1Level: PTClassification code 10004939Term: Bipolar I disorderEUCTR2008-007190-20-BGAstraZeneca AB350
进行中（未招募）
不适用
A multicentre, multinational, double-blind, randomised, parallel group, placebo controlled trial of ethyl-EPA ethyl-Icosapent in patients with Huntington s Disease - NDEUCTR2005-002088-98-ITAMARIN NEUROSCIENCE LTD240